{"nctId":"NCT01837277","briefTitle":"Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients","startDateStruct":{"date":"2017-12-15","type":"ACTUAL"},"conditions":["Severely Immunocompromised HIV Patients"],"count":186,"armGroups":[{"label":"Dolutegravir","type":"EXPERIMENTAL","interventionNames":["Drug: Dolutegravir 50 mg"]},{"label":"Efavirenz","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Efavirenz-based regimens"]}],"interventions":[{"name":"Dolutegravir 50 mg","otherNames":["Tivicay"]},{"name":"Efavirenz-based regimens","otherNames":["Efavirenz"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with confirmed HIV-1 infection (positive Western blot or plasma HIV-1 RNA \\>1,000 copies/ml)\n* No previous use of any ARV drug (drug-naïve patients)\n* Presence of clinical symptoms according to Rio de Janeiro / Caracas´ AIDS definition (Asthenia, Cachexia/Wasting, Cough, Dermatitis, persistent, Diarrhea, Fever, Lymphadenopathy, Candidiasis, oral, or hairy leukoplasia, Central nervous system dysfunction, Herpes zoster in individual younger than 60 years of age)), and/or any active AIDS-defining condition\n* Baseline CD4+ cells count equal or lower than 50 cells/mm3\n* Age equal or higher than 18 years\n* HIV-1 plasma viral load ≥ 1,000 copies of HIV-1 RNA/ml\n\nExclusion Criteria:\n\n* Undetectable plasma viral load at screening\n* CD4 cells count\\>50 cells/mm3\n* Asymptomatic individuals","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Early Mortality","description":"Proportion of deaths in each group","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]},{"type":"SECONDARY","title":"Viral Load","description":null,"classes":[]},{"type":"SECONDARY","title":"CD4 Count","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":92},"commonTop":["CNS disturbances"]}}}